Exelixis
EXEL
#1787
Rank
NZ$20.20 B
Marketcap
NZ$75.37
Share price
0.23%
Change (1 day)
23.76%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: NZ$83.65 NZD on 2000-07-26

Lowest end of day price: NZ$2.19 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 1.25%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$398.34-1.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.23 0.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$593.40 0.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$81.05-0.62%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$196.10-2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$100.14 1.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$97.03-1.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.00-13.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.48 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA